Original research articles |

* Olafiaklinikken STD Clinic, Grensen 5–7, 0159 Oslo;
Fürst Medical Laboratory, 1051 Oslo, Norway
Correspondence to: Professor Harald Moi, Olafiaklinikken, Grensen 5–7, 0159 Oslo, Norway Email: harald.moi{at}rikshospitalet.no
There are no evidence-based guidelines for the treatment of Mycoplasma genitalium-positive genital infection. In a retrospective survey, we analysed the treatment results of patients tested for M. genitalium at Olafia, Unit for Sexual Transmitted Diseases in Oslo. Out of 10,109 patients, 452 had a positive polymerase chain reaction. Between 72% and 100% of patients in the different treatment groups returned for test of cure after four to five weeks. First-line treatment with 1 g single dose azithromycin had a recovery rate of 79%. It was as effective as an extended five-days' course of azithromycin. Ofloxacin 200 mg b.i.d for 10 days cured 56% and moxifloxacin 400 mg o.d. for seven days as either second-, third- or fourth-line treatment after azithromycin or ofloxacin failure cured 100%. Azithromycin 1 g as a single dose seems to be the best choice of treatment for M. genitalium, with moxifloxacin 400 mg x 1 for seven days if treatment fails.
Key Words: Mycoplasma genitalium treatment azithromycin moxifloxacin
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. Hamasuna, J. S. Jensen, and Y. Osada Antimicrobial Susceptibilities of Mycoplasma genitalium Strains Examined by Broth Dilution and Quantitative PCR Antimicrob. Agents Chemother., November 1, 2009; 53(11): 4938 - 4939. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Shahmanesh, H Moi, F Lassau, and M Janier 2009 European Guideline on the Management of Male Non-gonococcal Urethritis Int J STD AIDS, July 1, 2009; 20(7): 458 - 464. [Full Text] [PDF] |
||||